Literature DB >> 6026104

Ceruloplasmin in Wilson's disease.

N A Holtzman, M A Naughton, F L Iber, B M Gaumnitz.   

Abstract

Ceruloplasmin was highly purified from one patient with Wilson's disease and partially purified from a second unrelated patient. The highly purified ceruloplasmin was indistinguishable from normal ceruloplasmin by electrophoresis, tryptic peptide map, oxidase activity, and copper, amino acid, and sugar composition. The partially purified ceruloplasmin was indistinguishable electrophoretically from normal ceruloplasmin. With penicillamine therapy, ceruloplasmin disappeared from the serum of the first patient; it reappeared after the drug was discontinued. The significance of this observation in regard to the basic defect in Wilson's disease is discussed.

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 6026104      PMCID: PMC297104          DOI: 10.1172/JCI105606

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  36 in total

1.  DISC ELECTROPHORESIS. II. METHOD AND APPLICATION TO HUMAN SERUM PROTEINS.

Authors:  B J DAVIS
Journal:  Ann N Y Acad Sci       Date:  1964-12-28       Impact factor: 5.691

2.  STUDIES ON GLYCOPROTEINS. I. THE CARBOHYDRATE PORTION OF HUMAN CERULOPLASMIN.

Authors:  G A JAMIESON
Journal:  J Biol Chem       Date:  1965-05       Impact factor: 5.157

3.  The determination of cuprous ion in copper proteins.

Authors:  G FELSENFELD
Journal:  Arch Biochem Biophys       Date:  1960-04       Impact factor: 4.013

4.  An improved procedure for starch-gel electrophoresis: further variations in the serum proteins of normal individuals.

Authors:  O SMITHIES
Journal:  Biochem J       Date:  1959-03       Impact factor: 3.857

5.  Wilson's disease; report of a case with normal serum ceruloplasmin level.

Authors:  E ENGER
Journal:  Acta Med Scand       Date:  1959-02-25

6.  [Study of ceruloplasimin in human serum by agar electrophoresis and immuno-electrophoretic analysis; colorimetric microdetection of protein-bound copper].

Authors:  J URIEL; H GOTZ; P GRABAR
Journal:  Schweiz Med Wochenschr       Date:  1957-04-07

7.  A modified ninhydrin reagent for the photometric determination of amino acids and related compounds.

Authors:  S MOORE; W H STEIN
Journal:  J Biol Chem       Date:  1954-12       Impact factor: 5.157

8.  Method for the determination of hexosamines in tissues.

Authors:  N F BOAS
Journal:  J Biol Chem       Date:  1953-10       Impact factor: 5.157

9.  Studies on copper metabolism. XIV. Copper, ceruloplasmin and oxidase activity in sera of normal human subjects, pregnant women, and patients with infection, hepatolenticular degeneration and the nephrotic syndrome.

Authors:  H MARKOWITZ; C J GUBLER; J P MAHONEY; G E CARTWRIGHT; M M WINTROBE
Journal:  J Clin Invest       Date:  1955-10       Impact factor: 14.808

10.  Caeruloplasmin as demonstrated by starch gel electrophoresis.

Authors:  J N CUMINGS; C J EARL
Journal:  J Clin Pathol       Date:  1960-01       Impact factor: 3.411

View more
  4 in total

1.  Molecular pathology of ceruloplasmin.

Authors:  S A Neifakh; I M Vasiletz; M M Shavlovsky
Journal:  Biochem Genet       Date:  1972-04       Impact factor: 1.890

2.  Measurement of blood holoceruloplasmin by EIA using a mouse monoclonal antibody directed to holoceruloplasmin. Implication for mass screening of Wilson disease.

Authors:  F Endo; K Taketa; K Nakamura; H Awata; A Tanoue; Y Eda; I Matsuda
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

3.  Blue blood.

Authors: 
Journal:  Br Med J       Date:  1967-11-25

4.  [Quantitative determination and phenotyping of ceruloplasmin in morbus Wilson (author's transl)].

Authors:  H W Goedde; H G Benkmann; J Lange; H Harders
Journal:  Klin Wochenschr       Date:  1975-08-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.